Taiwan FDA registration 39154efa9e651cd0b163bcd3a02ab2a0

“EUROIMMUN” Anti-Glutamate receptor (type NMDA) IIFT

TW: “歐蒙” 免疫螢光法抗麩胺酸受體(NMDA)抗體檢測試劑
Taiwan flagTaiwan·Risk Class 2·MD·EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG·Registered Jun 12, 2018 – Jun 12, 2028Active
Registration details
Analysis ID
39154efa9e651cd0b163bcd3a02ab2a0
License Form
Ministry of Health Medical Device Import No. 031145
Customs Code
DHA05603114502
Company information
Manufacturer Country
Germany
Product details
Intended Use
This product is used for in vitro qualitative or semi-quantitative detection of anti-glutaminate receptor (NMDA type) antibody immunoglobulin IgG antibodies in human serum, plasma or cerebrospinal fluid (CSF) samples.
Product Type (Level 1)
C Immunology and microbiology devices
Product Type (Level 2)
C5660 Multiple autologous antibody immunoassay system
Import Information
Imported from abroad
Dates and status
Registration Date
Jun 12, 2018
Expiry Date
Jun 12, 2028
About this record

Access comprehensive regulatory information for “EUROIMMUN” Anti-Glutamate receptor (type NMDA) IIFT in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 39154efa9e651cd0b163bcd3a02ab2a0 and manufactured by EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG. The authorized representative in Taiwan is EUROIMMUN (SOUTH EAST ASIA) PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices